Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

7.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.4K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

84.4K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
84.4K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

5.6K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiolabeled Coordination Polymer-Loaded Microneedles for Synergistic Melanoma Brachytherapy-Immunotherapy via STING Activation and Pyroptosis.

Exploration (Beijing, China)·2026
Same author

Exploring the immune landscape and immunotherapy relevance of ER stress-related lncRNAs in melanoma through multi-omics and explainable machine learning.

BMC cancer·2026
Same author

A two-stage workflow for vitiligo diagnosis: clinical characteristic classification and large language model (LLM)-based report generation.

Frontiers in immunology·2026
Same author

First dermoscopic characterization and histopathological correlation of panfolliculoma: a case report and review of the literature.

Frontiers in medicine·2026
Same author

Combined organic amendments reduce Cd accumulation in double-cropping rice by restructuring soil bacterial communities.

Ecotoxicology and environmental safety·2026
Same author

Enriching microbes capable of fluorotelomer acid defluorination: thermodynamic constraints and experimental challenges.

NPJ emerging contaminants·2026
Same journal

Characterization of Circ_0048766: an oncogenic circular rna promoting triple-negative breast cancer progression via the miR-329-3p/CXCR4 axis and regulated by METTL3.

Cancer cell international·2026
Same journal

Limb-bud and heart (LBH) promotes expansion and survival of esophageal adenocarcinoma cells.

Cancer cell international·2026
Same journal

PTX3 facilitates tumor cell migration and invasion through the miR-1255b-2-3p/CYP2J2 axis in oral squamous cell carcinoma.

Cancer cell international·2026
Same journal

From heterogeneity to mechanism: a systems-level analysis pinpoints the S100A8/A9 axis in colorectal cancer.

Cancer cell international·2026
Same journal

The pro-metastatic role of microbiota in tumors: a comprehensive review.

Cancer cell international·2026
Same journal

Single-cell-marker-based subtyping and multi-level analyses uncover the prognostic effects, dysregulations and therapeutic indicative potential of an eight-gene signature in lung adenocarcinoma.

Cancer cell international·2026
See all related articles

Related Experiment Video

Updated: Dec 9, 2025

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.3K

The relationship between TRAF6 and tumors.

Jiaoduan Li1,2,3,4,5, Nian Liu1,2,3,4,5, Ling Tang1,2,3,4,5

  • 1Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan China.

Cancer Cell International
|September 9, 2020
PubMed
Summary
This summary is machine-generated.

Tumor necrosis factor receptor-associated factor 6 (TRAF6) is upregulated in many cancers, driving tumor growth and spread. Targeting TRAF6 presents a promising new strategy for cancer treatment.

Keywords:
AP-1E3 ubiquitin ligaseNF-κBTRAF6Tumorigenesis

More Related Videos

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.6K

Related Experiment Videos

Last Updated: Dec 9, 2025

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.3K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.6K

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Tumor necrosis factor receptor (TNFR)-related factors (TRAFs) are key signaling molecules.
  • TRAF6 is one of seven TRAF family members.
  • TRAF6 is frequently upregulated in various tumors.

Purpose of the Study:

  • To review and analyze the role of TRAF6 in tumorigenesis and cancer development.
  • To explore TRAF6's oncogenic characteristics and involvement in tumor progression.
  • To discuss TRAF6 as a potential therapeutic target in cancer treatment.

Main Methods:

  • Literature review of studies on TRAF6 and cancer.
  • Analysis of signaling pathways regulated by TRAF6 in tumorigenesis.
  • Synthesis of current research on TRAF6's function in tumor invasion and metastasis.

Main Results:

  • TRAF6 exhibits oncogenic properties, promoting tumor initiation and development.
  • TRAF6 is implicated in tumor invasion and metastasis through diverse signaling pathways.
  • Upregulation of TRAF6 is a common feature in many types of cancer.

Conclusions:

  • TRAF6 plays a critical role in cancer progression.
  • Targeting TRAF6 offers a novel therapeutic strategy for various cancers.
  • Further research into TRAF6 signaling pathways is warranted for effective cancer therapies.